Circassia Group Plc
NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled N… Read more
Market Cap & Net Worth: Circassia Group Plc (CSSPF)
Circassia Group Plc (OTCGREY:CSSPF) has a market capitalization of $313.45 Million ($313.45 Million) as of March 19, 2026. Listed on the OTCGREY stock exchange, this USA-based company holds position #13963 globally and #5695 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Circassia Group Plc's stock price $0.75 by its total outstanding shares 417934328 (417.93 Million).
Circassia Group Plc Market Cap History: 2016 to 2025
Circassia Group Plc's market capitalization history from 2016 to 2025. Data shows change from $420.19 Million to $313.45 Million (-16.22% CAGR).
Circassia Group Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Circassia Group Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
7.50x
Circassia Group Plc's market cap is 7.50 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
84.72x
Circassia Group Plc's market cap is 84.72 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $420.19 Million | $23.10 Million | -$137.30 Million | 18.19x | N/A |
| 2017 | $492.54 Million | $46.30 Million | -$99.10 Million | 10.64x | N/A |
| 2018 | $351.82 Million | $48.30 Million | -$117.10 Million | 7.28x | N/A |
| 2020 | $171.98 Million | $23.90 Million | -$33.50 Million | 7.20x | N/A |
| 2021 | $187.61 Million | $27.90 Million | $3.60 Million | 6.72x | 52.11x |
| 2022 | $187.61 Million | $31.30 Million | $16.10 Million | 5.99x | 11.65x |
| 2023 | $316.25 Million | $36.80 Million | $10.70 Million | 8.59x | 29.56x |
| 2024 | $313.45 Million | $41.80 Million | $3.70 Million | 7.50x | 84.72x |
Competitor Companies of CSSPF by Market Capitalization
Companies near Circassia Group Plc in the global market cap rankings as of March 19, 2026.
Key companies related to Circassia Group Plc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Circassia Group Plc Historical Marketcap From 2016 to 2025
Between 2016 and today, Circassia Group Plc's market cap moved from $420.19 Million to $ 313.45 Million, with a yearly change of -16.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $313.45 Million | 0.00% |
| 2024 | $313.45 Million | -0.89% |
| 2023 | $316.25 Million | +68.57% |
| 2022 | $187.61 Million | 0.00% |
| 2021 | $187.61 Million | +9.09% |
| 2020 | $171.98 Million | +46.65% |
| 2019 | $117.27 Million | -66.67% |
| 2018 | $351.82 Million | -28.57% |
| 2017 | $492.54 Million | +17.22% |
| 2016 | $420.19 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Circassia Group Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $313.45 Million USD |
| MoneyControl | $313.45 Million USD |
| MarketWatch | $313.45 Million USD |
| marketcap.company | $313.45 Million USD |
| Reuters | $313.45 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.